United States · 
Who invested in Immunexpress?
Immunexpress's investors include Debiopharm Group.
United States · Venture startup
Who invested in Immunexpress
Funding summaryUpdated 26 Oct 2026
$6.0Mraised across 1 round since 2014, from 1 source
- Latest round
- Venture, $6.0MMar 2014
- Investors
- 1
The rounds
- Mar 2014
Founders and team
From Immunexpress's own website: 6 on the team.
- Jane Papadaki MarkleyVice President, Market Development and Commercial Operations
- Brian FlanneryNon-Executive Director
- Krupa NavalkarDirector, Bioinformatics – PhD in Biological Design
- LaKesha Hunt-DickensDirector, Quality & Regulatory Affairs -- MBA, MS
- Robert LilleyChairman – BA (Yale)
- Silvia CermelliDirector of Clinical Operations – PhD (Cell Biology)
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Immunexpress
How much has Immunexpress raised?
Immunexpress has raised $6.0M across 1 round since 2014.
When did Immunexpress last raise?
Immunexpress's most recent round was a Venture of $6.0M in Mar 2014.
What was Immunexpress's biggest round?
Its most recent round, $6.0M in Mar 2014, is also its largest on record.
Who backed Immunexpress first?
Immunexpress's first round on record, in Mar 2014, was backed by Debiopharm Group.
What stage is Immunexpress at?
Immunexpress's latest named round is a Venture, in Mar 2014.
Where is Immunexpress based?
Immunexpress is based in the United States.
Companies like Immunexpress
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.